Samsung Life Insurance (A032830) Q2 2024 earnings summary

Executive summary

• Consolidated net profit for H1 2024 reached KRW 1,369 billion, up 40.5% year-on-year, driven by strong insurance service results, health market expansion, and increased investment profit.

• CSM balance rose to KRW 12.7 trillion, with robust health new business CSM growth of nearly 60% year-on-year, and health products now comprising 54% of new business CSM.

• Exclusive channel accounted for 73% of new business APE, with exclusive FC headcount increasing by over 2,300 year-to-date, reinforcing channel dominance.

• The group maintains a leading position in the domestic life insurance market, with diversified operations in credit cards, asset management, and overseas insurance.

• The group is rated AAA by major Korean credit agencies, reflecting strong financial stability and market leadership.

Financial highlights

• Total assets as of June 2024 were KRW 320 trillion; invested assets at KRW 222 trillion.

• Net income attributable to controlling interests for H1 2024: KRW 1,368.5 billion, up from KRW 974.2 billion in H1 2023.

• Shareholders' equity stood at KRW 41.5 trillion, down KRW 2.8 trillion year-to-date, mainly due to FSS liability discount rate changes.

• Insurance profit for H1 was KRW 712 billion; investment profit was KRW 1.1 trillion.

• Investment yield for H1 was 3.3%, supported by diversified assets and stable dividend income.

Outlook and guidance

• Year-end CSM balance expected to exceed KRW 13 trillion, with annual new business CSM guidance raised to at least KRW 3.2–3.3 trillion.

• Plans to expand high-margin health product sales and maintain robust insurance profit through efficiency and risk management.

• Shareholder return policy targets a 50% payout ratio in the next 3–4 years, with gradual annual increases.

• K-ICS ratio projected in the 200-210% range as of June 2024.

• The group plans to expand insurance and asset management offerings, focusing on digital transformation and overseas growth.